We congratulate the six researchers at the Department of Medicine, Huddinge who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2029. Together, the MedH researchers are awarded grants of SEK 23 million.
, Hematology Unit/HERM.
Title: Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental
studies.
Amount granted for 2025-2027: SEK 3 750 000.
, Hematology Unit/HERM.
Title: Targeting SAMHD1 in relapsed/refractory AML: The FLAsH-IV trial.
Amount granted for 2025-2029: SEK 5 000 000.
, Hematology Unit/HERM.
Title: Identification of cytotoxic, resilient MSLN CAR T cells for solid tumors treatment.
Amount granted for 2025-2027: SEK 3 000 000.
, Center for Infectious Medicine (CIM).
Title: Off-the-shelf Adaptive NK Cell Therapy Guided by Protein Biologics and Precision Engineering.
Amount granted for 2025-2027: SEK 5 250 000.
, Hematology Unit/HERM.
Title: Exploring Stem and Immune Cell Dynamics Post- Relapse in Myelodysplastic Syndrome Patients Following Allogeneic Stem Cell Transplantation.
Amount granted for 2025-2027: SEK 3 000 000.
, Hematology Unit/HERM.
Title: Identification and Elucidation of druggable targets to increase NK cells functions against Cancer.
Amount granted for 2025-2027: SEK 3 000 000.
